All Stories

  1. IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
  2. Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury
  3. Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury
  4. Lung development and emerging roles for type 2 immunity
  5. Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease